BZPEERReading, trust and collaboration for research
Menu

Discover

GraphFollow connections around a paper, topic or saved view.

Workspaces

HomePick up where your research flow left off.InboxHandle requests, replies and notifications from one place.CollectionsCurate reading lists, evidence sets and shareable dossiers.ResearchSee your private provenance graph, trail and imports.CollaborationMove from discovery into focused discussion rooms.PublishDraft, preview and publish full-text research articles.

Network

ExpertsFind specialists worth following or asking for help.CommunitiesJoin research circles organized around shared work.PartnersSee external organizations active around the same topics.

Opportunities

ListingsBrowse roles, calls and collaborations with clearer fit signals.

Account

Log inReturn to your reading and collaboration workspace.Create accountStart saving work, following people and joining teams.
Log inCreate account

Researcher profile

Elizabeth A. Stuart

Elizabeth A. Stuart contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate
MethodologyApplications

Trust snapshot

Quick read

Trust 21 - EmergingVerification L1Unclaimed author
7works
0followers
2topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

7 published item(s)

preprint2023arXiv

Causal mediation analysis: From simple to more robust strategies for estimation of marginal natural (in)direct effects

This paper aims to provide practitioners of causal mediation analysis with a better understanding of estimation options. We take as inputs two familiar strategies (weighting and model-based prediction) and a simple way of combining them (weighted models), and show how a range of estimators can be generated, with different modeling requirements and robustness properties. The primary goal is to help build intuitive appreciation for robust estimation that is conducive to sound practice. A second goal is to provide a "menu" of estimators that practitioners can choose from for the estimation of marginal natural (in)direct effects. The estimators generated from this exercise include some that coincide or are similar to existing estimators and others that have not previously appeared in the literature. We note several different ways to estimate the weights for cross-world weighting based on three expressions of the weighting function, including one that is novel; and show how to check the resulting covariate and mediator balance. We use a random continuous weights bootstrap to obtain confidence intervals, and also derive general asymptotic variance formulas for the estimators. The estimators are illustrated using data from an adolescent alcohol use prevention study.

0 citations0 reviewsNo code linkedOpen access
preprint2022arXiv

Methodological considerations for estimating policy effects in the context of co-occurring policies

Understanding how best to estimate state-level policy effects is important, and several unanswered questions remain, particularly about the ability of statistical models to disentangle the effects of concurrently enacted policies. In practice, many policy evaluation studies do not attempt to control for effects of co-occurring policies, and this issue has not received extensive attention in the methodological literature to date. In this study, we utilized Monte Carlo simulations to assess the impact of co-occurring policies on the performance of commonly-used statistical models in state policy evaluations. Simulation conditions varied effect sizes of the co-occurring policies and length of time between policy enactment dates, among other factors. Outcome data (annual state-specific opioid mortality rate per 100,000) were obtained from 1999-2016 National Vital Statistics System (NVSS) Multiple Cause of Death mortality files, thus yielding longitudinal annual state-level data over 18 years from 50 states. When co-occurring policies are ignored (i.e., omitted from the analytic model), our results demonstrated that high relative bias (>85%) arises, particularly when policies are enacted in rapid succession. Moreover, as expected, controlling for all co-occurring policies will effectively mitigate the threat of confounding bias; however, effect estimates may be relatively imprecise (i.e., larger variance) when policies are enacted in near succession. Our findings highlight several key methodological issues regarding co-occurring policies in the context of opioid-policy research yet also generalize more broadly to evaluation of other state-level policies, such as policies related to firearms or COVID-19, showcasing the need to think critically about co-occurring policies that are likely to influence the outcome when specifying analytic models.

0 citations0 reviewsNo code linkedOpen access
preprint2021arXiv

Global Trends and Predictors of Face Mask Usage During the COVID-19 Pandemic

Background: Guidelines and recommendations from public health authorities related to face masks have been essential in containing the COVID-19 pandemic. We assessed the prevalence and correlates of mask usage during the pandemic. Methods: We examined a total of 13,723,810 responses to a daily cross-sectional representative online survey in 38 countries who completed from April 23, 2020 to October 31, 2020 and reported having been in public at least once during the last seven days. The outcome was individual face mask usage in public settings, and the predictors were country fixed effects, country-level mask policy stringency, calendar time, individual sociodemographic factors, and health prevention behaviors. Associations were modelled using survey-weighted multivariable logistic regression. Findings: Mask-wearing varied over time and across the 38 countries. While some countries consistently showed high prevalence throughout, in other countries mask usage increased gradually, and a few other countries remained at low prevalence. Controlling for time and country fixed effects, sociodemographic factors (older age, female gender, education, urbanicity) and stricter mask-related policies were significantly associated with higher mask usage in public settings, while social behaviors considered risky in the context of the pandemic (going out to large events, restaurants, shopping centers, and socializing outside of the household) were associated with lower mask use. Interpretation: The decision to wear a face mask in public settings is significantly associated with sociodemographic factors, risky social behaviors, and mask policies. This has important implications for health prevention policies and messaging, including the potential need for more targeted policy and messaging design.

0 citations0 reviewsNo code linkedOpen access
preprint2020arXiv

Generalizing Randomized Trial Findings to a Target Population using Complex Survey Population Data

Randomized trials are considered the gold standard for estimating causal effects. Trial findings are often used to inform policy and programming efforts, yet their results may not generalize well to a relevant target population due to potential differences in effect moderators between the trial and population. Statistical methods have been developed to improve generalizability by combining trials and population data, and weighting the trial to resemble the population on baseline covariates.Large-scale surveys in fields such as health and education with complex survey designs are a logical source for population data; however, there is currently no best practice for incorporating survey weights when generalizing trial findings to a complex survey. We propose and investigate ways to incorporate survey weights in this context. We examine the performance of our proposed estimator in simulations by comparing its performance to estimators that ignore the complex survey design.We then apply the methods to generalize findings from two trials - a lifestyle intervention for blood pressure reduction and a web-based intervention to treat substance use disorders - to their respective target populations using population data from complex surveys. The work highlights the importance in properly accounting for the complex survey design when generalizing trial findings to a population represented by a complex survey sample.

0 citations0 reviewsNo code linkedOpen access
preprint2020arXiv

Propensity score analysis with latent covariates: Measurement error bias correction using the covariate's posterior mean, aka the inclusive factor score

We address measurement error bias in propensity score (PS) analysis due to covariates that are latent variables. In the setting where latent covariate $X$ is measured via multiple error-prone items $\mathbf{W}$, PS analysis using several proxies for $X$ -- the $\mathbf{W}$ items themselves, a summary score (mean/sum of the items), or the conventional factor score (cFS , i.e., predicted value of $X$ based on the measurement model) -- often results in biased estimation of the causal effect, because balancing the proxy (between exposure conditions) does not balance $X$. We propose an improved proxy: the conditional mean of $X$ given the combination of $\mathbf{W}$, the observed covariates $Z$, and exposure $A$, denoted $X_{WZA}$. The theoretical support, which applies whether $X$ is latent or not (but is unobserved), is that balancing $X_{WZA}$ (e.g., via weighting or matching) implies balancing the mean of $X$. For a latent $X$, we estimate $X_{WZA}$ by the inclusive factor score (iFS) -- predicted value of $X$ from a structural equation model that captures the joint distribution of $(X,\mathbf{W},A)$ given $Z$. Simulation shows that PS analysis using the iFS substantially improves balance on the first five moments of $X$ and reduces bias in the estimated causal effect. Hence, within the proxy variables approach, we recommend this proxy over existing ones. We connect this proxy method to known results about weighting/matching functions (Lockwood & McCaffrey, 2016; McCaffrey, Lockwood, & Setodji, 2013). We illustrate the method in handling latent covariates when estimating the effect of out-of-school suspension on risk of later police arrests using Add Health data.

0 citations0 reviewsNo code linkedOpen access
preprint2020arXiv

Sensitivity analyses for effect modifiers not observed in the target population when generalizing treatment effects from a randomized controlled trial: Assumptions, models, effect scales, data scenarios, and implementation details

Background: Randomized controlled trials are often used to inform policy and practice for broad populations. The average treatment effect (ATE) for a target population, however, may be different from the ATE observed in a trial if there are effect modifiers whose distribution in the target population is different that from that in the trial. Methods exist to use trial data to estimate the target population ATE, provided the distributions of treatment effect modifiers are observed in both the trial and target population -- an assumption that may not hold in practice. Methods: The proposed sensitivity analyses address the situation where a treatment effect modifier is observed in the trial but not the target population. These methods are based on an outcome model or the combination of such a model and weighting adjustment for observed differences between the trial sample and target population. They accommodate several types of outcome models: linear models (including single time outcome and pre- and post-treatment outcomes) for additive effects, and models with log or logit link for multiplicative effects. We clarify the methods' assumptions and provide detailed implementation instructions. Illustration: We illustrate the methods using an example generalizing the effects of an HIV treatment regimen from a randomized trial to a relevant target population. Conclusion: These methods allow researchers and decision-makers to have more appropriate confidence when drawing conclusions about target population effects.

0 citations0 reviewsNo code linkedOpen access
preprint2020arXiv

Transportability of Outcome Measurement Error Correction: from Validation Studies to Intervention Trials

Many lifestyle intervention trials depend on collecting self-reported outcomes, like dietary intake, to assess the intervention's effectiveness. Self-reported outcome measures are subject to measurement error, which could impact treatment effect estimation. External validation studies measure both self-reported outcomes and an accompanying biomarker, and can therefore be used for measurement error correction. Most validation data, though, are only relevant for outcomes under control conditions. Statistical methods have been developed to use external validation data to correct for outcome measurement error under control, and then conduct sensitivity analyses around the error under treatment to obtain estimates of the corrected average treatment effect. However, an assumption underlying this approach is that the measurement error structure of the outcome is the same in both the validation sample and the intervention trial, so that the error correction is transportable to the trial. This may not always be a valid assumption to make. In this paper, we propose an approach that adjusts the validation sample to better resemble the trial sample and thus leads to more transportable measurement error corrections. We also formally investigate when bias due to poor transportability may arise. Lastly, we examine the method performance using simulation, and illustrate them using PREMIER, a multi-arm lifestyle intervention trial measuring self-reported sodium intake as an outcome, and OPEN, a validation study that measures both self-reported diet and urinary biomarkers.

0 citations0 reviewsNo code linkedOpen access